The Pharmaceutical Development Team at Journey Colab focuses on formulating, optimizing, and testing psychedelic compounds, including mescaline, to meet FDA regulatory standards for mental health therapies. Their work involves chemical synthesis, preclinical studies, and collaboration with clinical research teams to ensure safety, efficacy, and scalability of the compounds.
View all